Anh Nguyen

Anh received a combined BS-MD degree from the New Jersey Medical School, and an MBA from the University of Chicago Booth School of Business. He completed both his residency in anesthesiology and a fellowship in cardiovascular anesthesiology at the Massachusetts General Hospital - Harvard Medical School. 

​

Anh is a 3-time Boston Marathon finisher, and is a 4-time IRONMAN finisher.

Anh Nguyen, MD, MBA, is a pediatric cardiac anesthesiologist whose work involves both corporate strategy and global medical affairs at Xeris Pharmaceuticals, a platform specialty pharmaceutical company. 

​

Previously, Anh served as a medical officer for both the US Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS). He began his career in the life sciences as a global medical director at Baxter Healthcare. He is a Kauffman Fellow, FDA Commissioner's Fellow, and a Robert Wood Johnson Foundation Health Policy Fellow. During his RWJF fellowship on the US Senate Committee on Health, Education, Labor and Pensions he helped draft legislative policies as part of the "21st Century Cures Act," which was enacted into law in 2016. 

​

Anh regularly volunteers as active senior medical staff at the NIH, and is a recipient of the NIH Director's Award.

Anh served his fellowship under the Mentorship of Markham Luke, MD, PhD, the current Division Director of Therapeutic Products at the FDA Office of Generic Drugs. He is a member of Class 17, and was the first Kauffman Fellow from the operational arms of the U.S. Department of Health and Human Services.